Evaluation of a Cognitive Remediation Program for Mood Disorders

  • STATUS
    Recruiting
  • End date
    Feb 18, 2023
  • participants needed
    36
  • sponsor
    Centre hospitalier de Ville-Evrard, France
Updated on 25 January 2021

Summary

Psychotherapeutic management of cognitive disorders in patients suffering from a mood disorder

Details
Condition Taking Charge of Cognitive Impairment in Patients With Mood Disorders
Treatment Evaluation
Clinical Study IdentifierNCT04354974
SponsorCentre hospitalier de Ville-Evrard, France
Last Modified on25 January 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Is your age between 18 yrs and 65 yrs?
Gender: Male or Female
Do you have Taking Charge of Cognitive Impairment in Patients With Mood Disorders?
Do you have any of these conditions: Do you have Taking Charge of Cognitive Impairment in Patients With Mood Disorders??
Age between 18 and 65 years old
The patient's previous diagnosis of Bipolar-Related Disorder or Depressive Disorder according to the DSM-5 criteria
Mood stabilized with respect to depressive symptomatology (absence or presence of residual mild depressive symptoms (HDRS-17 18))
Mood stabilized with respect to manic symptomatology (absence or presence of residual mild manic symptoms (YMRS 8))
Stable and effective treatment at minimum dose for at least 2 months
Cognitive complaint expressed by the patient, and detected by the patient's referring psychiatrist
Free and Informed Consent Form read, initialled and signed
Patient affiliated to a social protection scheme or beneficiary of State Medical Aid
Patient knowing how to speak French -

Exclusion Criteria

Presence of a DSM-5 disorder, other than a mood, anxiety or personality disorder
Substance addiction or abuse (Alcohol, psychoactive substances) in the past 12 months
Manic, hypomanic or major depressive episode in the last 2 months
Somatic or neurological disorder which may lead to cognitive impairment
Current or less than one month's commitment to another research protocol
A neuropsychological assessment prior to 6 months
Patient under protective custody, guardianship or reinforced guardianship
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar
Name

Primary Contact

site
Name

Phone Email

0/250
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note